184 related articles for article (PubMed ID: 9638316)
1. [Intravesical instillation of trospium chloride, oxybutynin and verapamil for relaxation of the bladder detrusor muscle. A placebo controlled, randomized clinical test].
Fröhlich G; Burmeister S; Wiedemann A; Bulitta M
Arzneimittelforschung; 1998 May; 48(5):486-91. PubMed ID: 9638316
[TBL] [Abstract][Full Text] [Related]
2. Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability.
Halaska M; Ralph G; Wiedemann A; Primus G; Ballering-Brühl B; Höfner K; Jonas U
World J Urol; 2003 May; 20(6):392-9. PubMed ID: 12811500
[TBL] [Abstract][Full Text] [Related]
3. Trospium chloride and oxybutynin hydrochloride in a german study of adults with urinary urge incontinence: results of a 12-week, multicenter, randomized, double-blind, parallel-group, flexible-dose noninferiority trial.
Zellner M; Madersbacher H; Palmtag H; Stöhrer M; Bödeker RH;
Clin Ther; 2009 Nov; 31(11):2519-39. PubMed ID: 20109997
[TBL] [Abstract][Full Text] [Related]
4. Trospium chloride in patients with detrusor overactivity: meta-analysis of placebo-controlled, randomized, double-blind, multi-center clinical trials on the efficacy and safety of 20 mg trospium chloride twice daily.
Fröhlich G; Bulitta M; Strösser W
Int J Clin Pharmacol Ther; 2002 Jul; 40(7):295-303. PubMed ID: 12139206
[TBL] [Abstract][Full Text] [Related]
5. [Topical administration of oxybutynin hydrochloride in women with urge incontinence. Results of a prospective randomized double-blind study].
Enzelsberger H; Kurz C; Helmer H; Mittermayer F
Geburtshilfe Frauenheilkd; 1995 May; 55(5):240-3. PubMed ID: 7607378
[TBL] [Abstract][Full Text] [Related]
6. Trospium chloride for the treatment of overactive bladder with urge incontinence.
Singh-Franco D; Machado C; Tuteja S; Zapantis A
Clin Ther; 2005 May; 27(5):511-30. PubMed ID: 15978301
[TBL] [Abstract][Full Text] [Related]
7. [High-dose trospium chloride in therapy of detrusor hyperreflexia].
Madersbacher H; Stöhrer M; Richter R; Giannetti BM; Mürtz G
Urologe A; 1991 Jul; 30(4):260-3. PubMed ID: 1926674
[TBL] [Abstract][Full Text] [Related]
8. Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways.
Kim Y; Yoshimura N; Masuda H; de Miguel F; Chancellor MB
Urology; 2005 Feb; 65(2):238-42. PubMed ID: 15708029
[TBL] [Abstract][Full Text] [Related]
9. Urodynamic effects of intravesical oxybutynin chloride in conscious rats.
Yokoyama O; Ishiura Y; Nakamura Y; Ohkawa M
J Urol; 1996 Feb; 155(2):768-71. PubMed ID: 8558722
[TBL] [Abstract][Full Text] [Related]
10. Once daily trospium chloride is effective and well tolerated for the treatment of overactive bladder: results from a multicenter phase III trial.
Staskin D; Sand P; Zinner N; Dmochowski R;
J Urol; 2007 Sep; 178(3 Pt 1):978-83; discussion 983-4. PubMed ID: 17632131
[TBL] [Abstract][Full Text] [Related]
11. Intravesical instillation of human urine after oral administration of trospium, tolterodine and oxybutynin in a rat model of detrusor overactivity.
Kim Y; Yoshimura N; Masuda H; De Miguel F; Chancellor MB
BJU Int; 2006 Feb; 97(2):400-3. PubMed ID: 16430654
[TBL] [Abstract][Full Text] [Related]
12. [Topical use of oxybutynin hydrochloride in women with urge incontinence].
Enzelsberger H; Kurz C; Helmer H
Gynakol Geburtshilfliche Rundsch; 1994; 34(1):23-4. PubMed ID: 8019165
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, efficacy, and safety of intravesical formulation of oxybutynin in patients with detrusor overactivity.
Lehtoranta K; Tainio H; Lukkari-Lax E; Hakonen T; Tammela TL
Scand J Urol Nephrol; 2002 Feb; 36(1):18-24. PubMed ID: 12002352
[TBL] [Abstract][Full Text] [Related]
14. [The use of intravesical oxybutynin hydrochloride in patients with neurogenic bladder managed by intermittent catheterization].
Yokoyama O; Ishiura Y; Nakamura Y; Ohkawa M
Hinyokika Kiyo; 1995 Jul; 41(7):521-4. PubMed ID: 7668182
[TBL] [Abstract][Full Text] [Related]
15. Once-daily trospium chloride 60 mg extended-release provides effective, long-term relief of overactive bladder syndrome symptoms.
Zinner NR; Dmochowski RR; Staskin DR; Siami PF; Sand PK; Oefelein MG
Neurourol Urodyn; 2011 Sep; 30(7):1214-9. PubMed ID: 21462240
[TBL] [Abstract][Full Text] [Related]
16. Intravesical instillation of oxybutynin hydrochloride therapy for patients with a neuropathic bladder.
Mizunaga M; Miyata M; Kaneko S; Yachiku S; Chiba K
Paraplegia; 1994 Jan; 32(1):25-9. PubMed ID: 8015832
[TBL] [Abstract][Full Text] [Related]
17. Trospium chloride treatment of overactive bladder.
Biastre K; Burnakis T
Ann Pharmacother; 2009 Feb; 43(2):283-95. PubMed ID: 19193592
[TBL] [Abstract][Full Text] [Related]
18. Responses of isolated normal human detrusor muscle to various spasmolytic drugs commonly used in the treatment of the overactive bladder.
Uckert S; Stief CG; Odenthal KP; Truss MC; Lietz B; Jonas U
Arzneimittelforschung; 2000 May; 50(5):456-60. PubMed ID: 10858873
[TBL] [Abstract][Full Text] [Related]
19. Control of detrusor hyperreflexia by the intravesical instillation of oxybutynine hydrochloride.
Madersbacher H; Jilg G
Paraplegia; 1991 Feb; 29(2):84-90. PubMed ID: 2023781
[TBL] [Abstract][Full Text] [Related]
20. Effects of the anticholinergic drug prifinium bromide on urinary bladder contractions in rat in vivo and in guinea-pig in vitro.
Terai T; Deguchi Y; Ohtsuka M; Kumada S
Arzneimittelforschung; 1991 Apr; 41(4):417-20. PubMed ID: 1677577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]